174 related articles for article (PubMed ID: 24479713)
1. Inhibitory effects of polypeptides derived from a snake venom C-type lectin, aggretin, on tumor cell-induced platelet aggregation.
Chang CH; Chung CH; Hsu CC; Peng HC; Huang TF
J Thromb Haemost; 2014 Apr; 12(4):540-9. PubMed ID: 24479713
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC-2/podoplanin-dependent platelet aggregation and lung metastasis.
Sasaki T; Shirai T; Tsukiji N; Otake S; Tamura S; Ichikawa J; Osada M; Satoh K; Ozaki Y; Suzuki-Inoue K
J Thromb Haemost; 2018 May; 16(5):960-972. PubMed ID: 29488681
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.
Suzuki-Inoue K; Kato Y; Inoue O; Kaneko MK; Mishima K; Yatomi Y; Yamazaki Y; Narimatsu H; Ozaki Y
J Biol Chem; 2007 Sep; 282(36):25993-6001. PubMed ID: 17616532
[TBL] [Abstract][Full Text] [Related]
4. The crystal structure of the platelet activator aggretin reveals a novel (alphabeta)2 dimeric structure.
Hooley E; Papagrigoriou E; Navdaev A; Pandey AV; Clemetson JM; Clemetson KJ; Emsley J
Biochemistry; 2008 Jul; 47(30):7831-7. PubMed ID: 18597489
[TBL] [Abstract][Full Text] [Related]
5. A novel mechanism of cytokine release in phagocytes induced by aggretin, a snake venom C-type lectin protein, through CLEC-2 ligation.
Chang CH; Chung CH; Hsu CC; Huang TY; Huang TF
J Thromb Haemost; 2010 Nov; 8(11):2563-70. PubMed ID: 20738764
[TBL] [Abstract][Full Text] [Related]
6. Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation.
Suzuki-Inoue K
J Biochem; 2011 Aug; 150(2):127-32. PubMed ID: 21693546
[TBL] [Abstract][Full Text] [Related]
7. Aggretin Venom Polypeptide as a Novel Anti-angiogenesis Agent by Targeting Integrin alpha2beta1.
Chung CH; Chang CH; Hsu CC; Lin KT; Peng HC; Huang TF
Sci Rep; 2017 Mar; 7():43612. PubMed ID: 28252668
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of the interaction of the snake venom rhodocytin with the platelet receptor CLEC-2.
Watson AA; O'Callaghan CA
Toxins (Basel); 2011 Aug; 3(8):991-1003. PubMed ID: 22069753
[TBL] [Abstract][Full Text] [Related]
9. Aggretin, a heterodimeric C-type lectin from Calloselasma rhodostoma (Malayan pit viper), stimulates platelets by binding to α2β1 integrin and glycoprotein Ib, activating Syk and phospholipase Cγ 2, but does not involve the glycoprotein VI/Fc receptor γ chain collagen receptor.
Navdaev A; Clemetson JM; Polgar J; Kehrel BE; Glauner M; Magnenat E; Wells TN; Clemetson KJ
J Biol Chem; 2001 Jun; 276(24):20882-9. PubMed ID: 11287424
[TBL] [Abstract][Full Text] [Related]
10. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood.
Suzuki-Inoue K; Osada M; Ozaki Y
J Thromb Haemost; 2017 Feb; 15(2):219-229. PubMed ID: 27960039
[TBL] [Abstract][Full Text] [Related]
11. Platelet CLEC-2: Roles Beyond Hemostasis.
Suzuki-Inoue K; Tsukiji N; Shirai T; Osada M; Inoue O; Ozaki Y
Semin Thromb Hemost; 2018 Mar; 44(2):126-134. PubMed ID: 28992650
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis.
Chang YW; Hsieh PW; Chang YT; Lu MH; Huang TF; Chong KY; Liao HR; Cheng JC; Tseng CP
Oncotarget; 2015 Dec; 6(40):42733-48. PubMed ID: 26528756
[TBL] [Abstract][Full Text] [Related]
13. A platform of C-type lectin-like receptor CLEC-2 for binding O-glycosylated podoplanin and nonglycosylated rhodocytin.
Nagae M; Morita-Matsumoto K; Kato M; Kaneko MK; Kato Y; Yamaguchi Y
Structure; 2014 Dec; 22(12):1711-1721. PubMed ID: 25458834
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.
Kato Y; Kaneko MK; Kunita A; Ito H; Kameyama A; Ogasawara S; Matsuura N; Hasegawa Y; Suzuki-Inoue K; Inoue O; Ozaki Y; Narimatsu H
Cancer Sci; 2008 Jan; 99(1):54-61. PubMed ID: 17944973
[TBL] [Abstract][Full Text] [Related]
15. The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis.
Sheng M; Sun R; Fu J; Lu G
BMC Cancer; 2024 Apr; 24(1):399. PubMed ID: 38561690
[TBL] [Abstract][Full Text] [Related]
16. The snake venom rhodocytin from Calloselasma rhodostoma- a clinically important toxin and a useful experimental tool for studies of C-type lectin-like receptor 2 (CLEC-2).
Bruserud Ø
Toxins (Basel); 2013 Apr; 5(4):665-74. PubMed ID: 23594438
[TBL] [Abstract][Full Text] [Related]
17. Thrombomodulation via CLEC-2 targeting.
O'Callaghan CA
Curr Opin Pharmacol; 2009 Apr; 9(2):90-5. PubMed ID: 19091630
[TBL] [Abstract][Full Text] [Related]
18. [Identification of the novel platelet activation receptor CLEC-2 and Its pathological and physiological roles].
Suzuki Inoue K; Inoue O; Ozaki Y
Rinsho Byori; 2010 Dec; 58(12):1193-202. PubMed ID: 21348239
[TBL] [Abstract][Full Text] [Related]
19. Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist.
Huang TF; Liu CZ; Yang SH
Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):1021-7. PubMed ID: 7639679
[TBL] [Abstract][Full Text] [Related]
20. Aggretin, a C-type lectin protein, induces platelet aggregation via integrin alpha(2)beta(1) and GPIb in a phosphatidylinositol 3-kinase independent pathway.
Chung CH; Peng HC; Huang TF
Biochem Biophys Res Commun; 2001 Jul; 285(3):689-95. PubMed ID: 11453648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
